Som for andre HMG- CoA- reduktasehæmmere ses forhøjede serum- transaminaser hos patienter, der behandles med {(Sær) navn}.
As with other HMG-CoA reductase inhibitors elevated serum transaminases have been reported in patients receiving {PRODUCT NAME}.